DigitUS Multiplikatorenhandreichung | Förderung von Schulentwicklungsprozessen zum Einsatz digitaler Medien im Unterricht im Rahmen des Projektes DigitUS

Informationen, Material und Methoden zur Förderung von Schulentwicklungsprozessen zum Einsatz digitaler Medien im Unterricht mithilfe von Professionellen Lerngemeinschaften

DigitUS 1. Klausurtag | Kick-Off der Lerngemeinschaft

In den Präsentationsfolien wird der Begriff der Professionellen Lerngemeinschaft und deren Integration in das Projekt DigitUS erklärt

COVID-19 AND THE ENVIRONMENT – THE ROLE OF THE PUBLIC HEALTH INSTITUTE

The Croatian National Health Care Act defines the areas of activities of the public health institute, including the activities of the epidemiology of infectious diseases and chronic non-communicable diseases, public health, health promotion, environmental health, microbiology, school and adolescent medicine, mental health and addiction prevention at Zagreb City level. This paper reviews the highly variable activities in the Andrija Štampar Teaching Institute of Public Health with the aim of promoting a comprehensive approach to the COVID-19 pandemic. Human and analytical resources in the Institute, activities and rapid implementation of innovations testify to the high capacities for adaptation to emerging risks. In the Institute, it is possible to carry out a whole range of tests and to monitor the environmental factors with predominant impact on human health and safety of the Zagreb environment. The supply of safe water for human consumption in the Republic of Croatia during the current COVID-19 crisis has been uninterrupted and in accordance with applicable legislation. Also, our laboratories have been developing and introducing a method for wastewater testing for SARS-CoV-2 presence. The sludge from wastewater treatment plants is used in agriculture, and potential risks associated with the COVID-19 outbreak should be assessed prior to each application on the soil. Increased use of disinfectants during the epidemic may present a higher risk to the aquatic environment. Air quality monitoring indicates a positive impact on air quality as result of isolation measures

Cost of Illness and its Predictors for Parkinson's Disease in Germany

Objective: To prospectively evaluate the health economic burden of patients with Parkinson's disease (PD) in Germany over a 6-month observation period and to identify the predictors of these costs. Study design and methods: Direct and indirect costs were evaluated in 145 patients with PD (mean age 67.3 +- 9.6 years). PD patients were recruited from an outpatient department for movement disorders, a specialised PD clinic, two office-based neurologists and general practitioners, all located in Germany, and were enrolled between January and June 2000. Relevant economic data were documented in a patient diary over the 6-month period. Clinical evaluations (Unified Parkinson's Disease Rating Scale [UPDRS]) were performed at baseline and at 3 and 6 months. Costs were derived from various German medical economic resources. Costs were calculated from the perspective of healthcare and transfer payment providers and the individual patient. Indirect costs for lost productivity were also calculated. Costs are presented as means +- standard deviation (SD). Multivariate regression analyses were performed to identify independent cost predictors. Costs are in year 2000-02 values. Results: We estimated average per patient direct, indirect and total costs for the 6-month observation period. The costs from the perspective of statutory health insurance (Gesetzliche Krankenkversicherung [GKV]) consisted of direct medical costs _1370 +- _3240, including rehabilitation (_420 +- _1630), hospitalisation (_710 +- _2520), outpatient treatment (_40 +- _30), ancillary treatment (_190 +- _280) and ambulatory diagnostic procedures (_10 +- _30). In addition, parkinsonian drug costs were _1520 +- _1250. Non-medical direct costs calculated from the GKV perspective were estimated to be _480 +- _1710, which included transportation (_10 +- _20), special equipment (_420 +- _1640), social/home-help services (_10 +- _110) and sickness benefit (_40 +- _540). The total medical (including drug costs) and non-medical direct costs for the GKV were _3380 +- _4230. Univariate predictors for GKV direct costs included occurrence of motor complications and falls, disease severity, nightmares and dementia. However, multivariate analyses only suggested disease severity and health-related quality of life as significant predictors. For nursing insurance, payments of _1330 +- _2890 were calculated. For retirement insurance, payments were _650 +- _1510 and there were patient (or caregiver) costs of _1490 +- _2730. Total indirect costs amounted to _3180 +- _6480. Conclusion: According to our study, PD puts a high financial burden on society and underscores the need for further economic and medical research to optimise treatment for PD.Cost-of-illness, Parkinson's-disease

DigitUS mebis-Metakurs | Erstellung von mebis Kursen

Mebis-Kurs, in dem das Erstellen von Mebis-Kursen erklärt wird. Es wird erklärt wie man im Mebis -Kurs verschiedene Lehrmaterialen und Aktivitäten wie Wikis, HP5 Aktivitäten, Feedback, Glossare anlegen kann

DigitUS mebis-Kurs | Kurs für Lerngemeinschaften

Ein Mebis-Kurs für die aus Lehrkräften bestehenden Lerngemeinschaften. Der Kurs begleitet die Klausurtage der Lerngemeinschaften in der DigitUS-Studie. Der Kurs behandelt Themen wie die Potentiale digitaler Werkzeuge, Unterrichtsgestaltung in Biologie und Mathematik sowie kognitive Aktivierung

DigitUS mebis-Kurs | Materialsammlung für Multiplikatorinnen und Multiplikatoren

Ein Mebis-Kurs für Multiplikator*innen, der als Begleitung der Klausurtage des DigitUS-Projekts dient. Der Kurs soll den Multiplikator*innen helfen nachhaltige professionelle Lerngemeinschaften zu bilden. Der Kurs enthält Informationen zu digitalen Medien und Tools sowie dem Nutzen von digitalen Medien für wirksamen Fachunterricht und Biologie und Mathematik, die Planung von Fachunterricht und die kognitive Aktivierung von Schüler*innen

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

Background Results from retrospective studies suggest that use of neuromuscular blocking agents during general anaesthesia might be linked to postoperative pulmonary complications. We therefore aimed to assess whether the use of neuromuscular blocking agents is associated with postoperative pulmonary complications. Methods We did a multicentre, prospective observational cohort study. Patients were recruited from 211 hospitals in 28 European countries. We included patients (aged ≥18 years) who received general anaesthesia for any in-hospital procedure except cardiac surgery. Patient characteristics, surgical and anaesthetic details, and chart review at discharge were prospectively collected over 2 weeks. Additionally, each patient underwent postoperative physical examination within 3 days of surgery to check for adverse pulmonary events. The study outcome was the incidence of postoperative pulmonary complications from the end of surgery up to postoperative day 28. Logistic regression analyses were adjusted for surgical factors and patients’ preoperative physical status, providing adjusted odds ratios (ORadj) and adjusted absolute risk reduction (ARRadj). This study is registered with ClinicalTrials.gov, number NCT01865513. Findings Between June 16, 2014, and April 29, 2015, data from 22803 patients were collected. The use of neuromuscular blocking agents was associated with an increased incidence of postoperative pulmonary complications in patients who had undergone general anaesthesia (1658 [7·6%] of 21694); ORadj 1·86, 95% CI 1·53–2·26; ARRadj –4·4%, 95% CI –5·5 to –3·2). Only 2·3% of high-risk surgical patients and those with adverse respiratory profiles were anaesthetised without neuromuscular blocking agents. The use of neuromuscular monitoring (ORadj 1·31, 95% CI 1·15–1·49; ARRadj –2·6%, 95% CI –3·9 to –1·4) and the administration of reversal agents (1·23, 1·07–1·41; –1·9%, –3·2 to –0·7) were not associated with a decreased risk of postoperative pulmonary complications. Neither the choice of sugammadex instead of neostigmine for reversal (ORadj 1·03, 95% CI 0·85–1·25; ARRadj –0·3%, 95% CI –2·4 to 1·5) nor extubation at a train-of-four ratio of 0·9 or more (1·03, 0·82–1·31; –0·4%, –3·5 to 2·2) was associated with better pulmonary outcomes. Interpretation We showed that the use of neuromuscular blocking drugs in general anaesthesia is associated with an increased risk of postoperative pulmonary complications. Anaesthetists must balance the potential benefits of neuromuscular blockade against the increased risk of postoperative pulmonary complications